Moneycontrol PRO
you are here: HomeNewsAjanta pharma
ajanta pharma
Jump to
  • Ajanta Pharma Consolidated June 2022 Net Sales at Rs 950.93 crore, up 27.13% Y-o-Y Jul 28, 2022 10:22 PM IST

    Ajanta Pharma Consolidated June 2022 Net Sales at Rs 950.93 crore, up 27.13% Y-o-Y

  • Ajanta Pharma Standalone June 2022 Net Sales at Rs 850.29 crore, up 14.48% Y-o-Y Jul 28, 2022 10:11 PM IST

    Ajanta Pharma Standalone June 2022 Net Sales at Rs 850.29 crore, up 14.48% Y-o-Y

  • Ajanta Pharma Q1 PAT may dip 12.7% YoY to Rs 151.6 cr: ICICI Direct Jul 13, 2022 07:10 PM IST

    Ajanta Pharma Q1 PAT may dip 12.7% YoY to Rs 151.6 cr: ICICI Direct

    Net Sales are expected to increase by 13.9 percent Y-o-Y (down 2.1 percent Q-o-Q) to Rs 852.3 crore, according to ICICI Direct.

  • Buy Ajanta Pharma; target of Rs 2378: Anand Rathi May 15, 2022 10:12 PM IST

    Buy Ajanta Pharma; target of Rs 2378: Anand Rathi

    Anand Rathi is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2378 in its research report dated May 11, 2022.

  • Buy Ajanta Pharma; target of Rs 2350: YES Securities May 12, 2022 09:16 PM IST

    Buy Ajanta Pharma; target of Rs 2350: YES Securities

    YES Securities is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2350 in its research report date May 10, 2022.

  • Buy Ajanta Pharma; target of Rs 2080: Motilal Oswal May 12, 2022 02:33 PM IST

    Buy Ajanta Pharma; target of Rs 2080: Motilal Oswal

    Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 2080 in its research report dated May 10, 2022.

  • Ajanta Pharma Q4 net profit falls 5% to Rs 151 crore May 10, 2022 08:18 PM IST

    Ajanta Pharma Q4 net profit falls 5% to Rs 151 crore

    The drug firm had reported a consolidated PAT (Profit After Tax) of Rs 159 crore in the January-March quarter of 2020-21 fiscal.

  • Ajanta Pharma Standalone March 2022 Net Sales at Rs 765.63 crore, up 2.35% Y-o-Y May 10, 2022 05:00 PM IST

    Ajanta Pharma Standalone March 2022 Net Sales at Rs 765.63 crore, up 2.35% Y-o-Y

  • Ajanta Pharma Consolidated March 2022 Net Sales at Rs 870.29 crore, up 14.99% Y-o-Y May 10, 2022 05:00 PM IST

    Ajanta Pharma Consolidated March 2022 Net Sales at Rs 870.29 crore, up 14.99% Y-o-Y

  • Buy Ajanta Pharma; target of Rs 2400: Ajcon Global Mar 10, 2022 10:10 PM IST

    Buy Ajanta Pharma; target of Rs 2400: Ajcon Global

    Ajcon Global is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated March 08, 2022.

  • Ajanta Pharma Consolidated December 2021 Net Sales at Rs 837.91 crore, up 11.91% Y-o-Y Feb 01, 2022 10:11 AM IST

    Ajanta Pharma Consolidated December 2021 Net Sales at Rs 837.91 crore, up 11.91% Y-o-Y

  • Ajanta Pharma Consolidated December 2021 Net Sales at Rs 837.91 crore, up 11.91% Y-o-Y Jan 31, 2022 11:23 PM IST

    Ajanta Pharma Consolidated December 2021 Net Sales at Rs 837.91 crore, up 11.91% Y-o-Y

  • Ajanta Pharma Standalone December 2021 Net Sales at Rs 808.58 crore, up 10.29% Y-o-Y Jan 31, 2022 11:22 PM IST

    Ajanta Pharma Standalone December 2021 Net Sales at Rs 808.58 crore, up 10.29% Y-o-Y

  • Ajanta Pharma Q3 net up 9% at Rs 192 crore Jan 31, 2022 06:41 PM IST

    Ajanta Pharma Q3 net up 9% at Rs 192 crore

    The Mumbai-based drug firm had reported a net profit of Rs 176.63 crore in the same period of the previous fiscal.

  • Ajanta Pharma board approves up to Rs 286-crore share buyback plan Dec 28, 2021 12:58 PM IST

    Ajanta Pharma board approves up to Rs 286-crore share buyback plan

    The company’s board has approved buyback of up to 11,20,000 fully paid-up shares of face value of Rs 2 each at a price of Rs 2,550 per share payable in cash, Ajanta Pharma said in a regulatory filing.

  • Ajanta Pharma gains 5% as board approves share buyback worth Rs 285 crore Dec 28, 2021 12:26 PM IST

    Ajanta Pharma gains 5% as board approves share buyback worth Rs 285 crore

    The board has fixed January 14, 2022 as the record date for the same.

  • Ajanta Pharma Standalone September 2021 Net Sales at Rs 823.71 crore, up 21.76% Y-o-Y Nov 08, 2021 07:00 PM IST

    Ajanta Pharma Standalone September 2021 Net Sales at Rs 823.71 crore, up 21.76% Y-o-Y

  • Ajanta Pharma Consolidated September 2021 Net Sales at Rs 884.80 crore, up 23.59% Y-o-Y Nov 02, 2021 02:22 PM IST

    Ajanta Pharma Consolidated September 2021 Net Sales at Rs 884.80 crore, up 23.59% Y-o-Y

  • Buy Ajanta Pharma; target of Rs 2780: Motilal Oswal Aug 02, 2021 04:36 PM IST

    Buy Ajanta Pharma; target of Rs 2780: Motilal Oswal

    Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 2780 in its research report dated July 30, 2021.

  • Ajanta Pharma Consolidated June 2021 Net Sales at Rs 747.99 crore, up 11.94% Y-o-Y Jul 30, 2021 12:11 PM IST

    Ajanta Pharma Consolidated June 2021 Net Sales at Rs 747.99 crore, up 11.94% Y-o-Y

  • Ajanta Pharma Standalone June 2021 Net Sales at Rs 742.72 crore, up 32.43% Y-o-Y Jul 30, 2021 12:11 PM IST

    Ajanta Pharma Standalone June 2021 Net Sales at Rs 742.72 crore, up 32.43% Y-o-Y

  • Ajanta Pharma renews residential lease in posh Mumbai apartment for Rs 18 lakh a month Jun 09, 2021 05:39 PM IST

    Ajanta Pharma renews residential lease in posh Mumbai apartment for Rs 18 lakh a month

    The Raheja Legend apartment is located in Worli. Real-estate experts say the deal clearly indicates that despite two waves of COVID-19, rentals in exclusive high-end apartment buildings have more or less remained stable.

  • Buy Ajanta Pharma; target of Rs 2205: Dolat Capital Market May 24, 2021 04:42 PM IST

    Buy Ajanta Pharma; target of Rs 2205: Dolat Capital Market

    Dolat Capital Market is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2205 in its research report dated April 30, 2021.

  • Ajanta Pharma Consolidated March 2021 Net Sales at Rs 756.84 crore, up 10.98% Y-o-Y May 04, 2021 03:22 PM IST

    Ajanta Pharma Consolidated March 2021 Net Sales at Rs 756.84 crore, up 10.98% Y-o-Y

  • Ajanta Pharma Standalone March 2021 Net Sales at Rs 748.07 crore, up 33.42% Y-o-Y May 04, 2021 03:01 PM IST

    Ajanta Pharma Standalone March 2021 Net Sales at Rs 748.07 crore, up 33.42% Y-o-Y

Sections
ISO 27001 - BSI Assurance Mark